Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,162,832
  • Shares Outstanding, K 21,312
  • Annual Sales, $ 0 K
  • Annual Income, $ -373,630 K
  • 60-Month Beta -0.43
  • Price/Sales 329.56
  • Price/Cash Flow N/A
  • Price/Book 5.80
Trade MDGL with:

Options Overview Details

View History
  • Implied Volatility 45.53% ( -6.34%)
  • Historical Volatility 32.10%
  • IV Percentile 6%
  • IV Rank 3.53%
  • IV High 156.35% on 02/23/24
  • IV Low 41.48% on 08/19/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 173
  • Volume Avg (30-Day) 243
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 24,785
  • Open Int (30-Day) 23,697

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -7.58
  • Number of Estimates 9
  • High Estimate -6.65
  • Low Estimate -11.32
  • Prior Year -5.34
  • Growth Rate Est. (year over year) -41.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
230.02 +4.39%
on 09/12/24
262.25 -8.44%
on 08/21/24
-19.05 (-7.35%)
since 08/20/24
3-Month
225.51 +6.48%
on 08/07/24
298.00 -19.42%
on 07/12/24
-27.67 (-10.33%)
since 06/20/24
52-Week
119.76 +100.50%
on 10/27/23
299.98 -19.95%
on 03/15/24
+78.70 (+48.75%)
since 09/20/23

Most Recent Stories

More News
Is Madrigal Pharmaceuticals Stock a Buy?

The biotech could be worth a lot more in 10 years.

NVO : 127.35 (-5.58%)
LLY : 923.41 (+0.91%)
MDGL : 241.34 (-0.38%)
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock

One player's minor pain is another's moderate gain.

MDGL : 241.34 (-0.38%)
NVO : 127.35 (-5.58%)
Madrigal: Q2 Earnings Snapshot

Madrigal: Q2 Earnings Snapshot

MDGL : 241.34 (-0.38%)
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?

Will being the first to its market ensure that its future is bright?

MDGL : 241.34 (-0.38%)
Is Madrigal Pharmaceuticals a Millionaire Maker?

Its revenue ramp-up is just starting, and its market looks lucrative.

MDGL : 241.34 (-0.38%)
Is Madrigal Pharmaceuticals Stock a Buy?

The company could become a prominent player in the biotech industry, but that might take a while.

MDGL : 241.34 (-0.38%)
The Best Biotech Stock to Invest $1,000 in Right Now

This stock may not be a slam dunk, but it's looking very promising.

MDGL : 241.34 (-0.38%)
LLY : 923.41 (+0.91%)
NVO : 127.35 (-5.58%)
VKTX : 70.63 (+3.62%)
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.

MDGL : 241.34 (-0.38%)
LLY : 923.41 (+0.91%)
Where Will Madrigal Pharmaceuticals Be in 3 Years?

The coast is clear for it to grow, for now.

MDGL : 241.34 (-0.38%)
NVO : 127.35 (-5.58%)
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Success isn't guaranteed, but both companies could become big winners.

VKTX : 70.63 (+3.62%)
MDGL : 241.34 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 263.82
2nd Resistance Point 256.00
1st Resistance Point 249.13
Last Price 241.34
1st Support Level 234.44
2nd Support Level 226.62
3rd Support Level 219.75

See More

52-Week High 299.98
Last Price 241.34
Fibonacci 61.8% 231.14
Fibonacci 50% 209.87
Fibonacci 38.2% 188.60
52-Week Low 119.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar